Emerald Clinical

Home
Singapore
Singapore
Emerald Clinical

Emerald Clinical is a global full-service CRO with 25+ years’ experience.

We deliver Phase I–IV & real-world studies worldwide, partnering with biotech & top pharma to advance therapies in Renal, Oncology, Autoimmune & more. With over 20 years of experience and more than 500 people managing 38 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.

10/09/2026

We are thrilled to welcome you join our "APAC Oncology Trials: Accelerate Global Development Timelines" on September 22.

📍 https://emeraldclinical.com/apac-oncology-trials-accelerate-global-development-timelines/?utm_campaign=webinar+-+APAC+Oncology+Trials&utm_source=facebook&utm_medium=organic_social&utm_content=1789028100

Luke Gill (VP, Global Head of Oncology at Emerald Clinical), Will Chen (Head of Regulatory Affairs at Emerald Clinical) and Rokuya Nochi (Executive Officer at EPS Corporation), they will reshape your development strategy:

•"Should I file my China IND before or after my Australian CTA?"

•"How do I align Japanese GCP requirements with my global monitoring plan?"

If you are a clinical operations lead, regulatory strategist, or portfolio manager, this is the session you cannot miss!

09/09/2026

At Emerald Clinical, it's the combination of deep APAC expertise, scientific rigor, therapeutic leadership, patient-centered thinking, and operational excellence.

From navigating complex regulatory environments across Asia-Pacific to delivering scalable, high-quality ex*****on, we help sponsors accelerate development while maintaining focus on what matters most: patients.

🔸 APAC market expertise
🔸 Scientific and therapeutic leadership
🔸 Patient-centered by design
🔸 Precision at scale
🔸 Proven operational agility

Together, these capabilities help sponsors move with greater confidence from strategy to ex*****on.

See what's possible - https://emeraldclinical.com/services/?utm_campaign=Services+2026&utm_source=facebook&utm_medium=organic_social&utm_content=1788941700

08/09/2026

🔬 Book a meeting with us at SOHO 2026.

Emerald Clinical Trials is excited to attend the Society of Hematologic Oncology (SOHO) Annual Meeting, September 9-12, 2026, with Sachin Kulkarni, Therapeutic Strategy Head, and Emily Todd, Director of Business Development.

📅 If you're attending SOHO, let's discuss how to accelerate your hematology-oncology development program with confidence.

Schedule a meeting with Sachin or Emily today. https://emeraldclinical.com/contact-us/?utm_campaign=SOHO+26&utm_source=facebook&utm_medium=organic_social&utm_content=1788855301

07/09/2026

Our U.S. offices will be closed for the holiday as we celebrate the hard work, dedication, and achievements of our colleagues and partners.

Wishing everyone a wonderful Labor Day weekend.

04/09/2026

What do sponsors value most in a CRO partner?

For one client, the answer was clear:

"We are very happy with the progress of the study under Emerald Clinical.

In separate meetings with different CROs working on the study, Emerald Clinical is the most responsive and pays the most attention to details."

In an industry where timelines are critical and every detail matters, our teams take pride in being responsive, collaborative, and relentlessly focused on study success.

That's the Emerald Clinical difference.

Ready to see how we can support your next clinical program?

Explore our capabilities: http://www.emeraldclinical.com?utm_campaign=Testimonial+2026&utm_source=facebook&utm_medium=organic_social&utm_content=1788509700

03/09/2026

Are you attending SOHO 2026 in Houston, September 9-12?

Connect with Sachin Kulkarni, Therapeutic Franchise Head, and Emily Todd, Director, Business Development, at SOHO 2026 to discuss how Emerald Clinical helps oncology sponsors navigate complex development pathways and reach critical endpoints faster.

Be sure to check out Sachin Kulkarni's featured video in this post, where he shares insights on the evolving oncology landscape and how strategic clinical development approaches can help sponsors accelerate program success.

From biomarker-driven strategies and adaptive trial designs to recruiting hard-to-enroll patient populations, our oncology experts partner with sponsors to optimize protocol design, improve trial efficiency, and accelerate the path to regulatory success.

Whether you're planning an early-phase study or advancing a late-stage program, we'd welcome the opportunity to discuss your clinical development goals and explore strategies to move your oncology program forward with confidence.

📅 Schedule a meeting with Sachin or Emily today: https://emeraldclinical.com/contact-us/?utm_campaign=SOHO+26&utm_source=facebook&utm_medium=organic_social&utm_content=1788423300

📍 See you at SOHO 2026!

02/09/2026

Ahead of Obesity & Innovation 2026, we're reflecting on the power of collaboration and innovation in clinical research.

This case study highlights the successful ex*****on of a multinational COVID-19 clinical trial during the peak of global lockdowns, resulting in the enrolment of over 1,000 patients across nearly 100 sites and delivering meaningful evidence in support of the fight against COVID-19.

Read the full case study here - https://emeraldclinical.com/insights/resources/major-covid-19-trial-at-height-of-global-lockdown-implemented-in-record-time/?utm_campaign=Cardiometabolic+Q3&utm_source=facebook&utm_medium=organic_social&utm_content=1788336900

We look forward to connecting with fellow industry professionals at the event to explore new ways to advance research, accelerate development timelines, and improve patient outcomes.

📍 See you at Obesity & Innovation 2026! Schedule a time to meet with us now. https://emeraldclinical.com/contact-us/?utm_campaign=Cardiometabolic+Q3&utm_source=facebook&utm_medium=organic_social&utm_content=1788336900

01/09/2026

officially launch our upcoming webinar: "APAC Oncology Trials: Accelerate Global Development Timelines" – taking place on Tuesday, September 22, 2026, in partnership with EPS

The full agenda and speaker lineup are now live on our event website, and registration is officially open.

Key takeaways

🔹 Regulatory pathways and local requirements in China and Japan, including PMDA considerations, CTA processes, ethnic sensitivity, bridging data and GCP requirements

🔹 Common protocol, site selection, enrollment and submission planning mistakes that can create downstream risk and delay program timelines

🔹 How to evaluate when APAC integration makes strategic sense, including realistic expectations for timeline compression and executive-level decision-making

The full agenda, speaker bios, and registration link are now available: https://emeraldclinical.com/apac-oncology-trials-accelerate-global-development-timelines/?utm_campaign=&utm_source=facebook&utm_medium=organic_social&utm_content=1788250500

Address

#32-01 300 Beach Road, The Concourse
Singapore
199555

Website

http://www.emeraldclinical.com/

Alerts

Be the first to know and let us send you an email when Emerald Clinical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Health & Beauty Business in Singapore?